Sendero Wealth Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$353K Buy
12,574
+221
+2% +$5.88K 0.04% 174
2025
Q4
$308K Buy
12,353
+135
+1% +$3.4K 0.03% 179
2025
Q3
$311K Buy
12,218
+2,646
+28% +$65.3K 0.04% 169
2025
Q2
$232K Buy
9,572
+28
+0.3% +$653 0.03% 181
2025
Q1
$242K Buy
9,544
+383
+4% +$10K 0.03% 168
2024
Q4
$243K Hold
9,161
0.04% 155
2024
Q3
$265K Hold
9,161
0.04% 152
2024
Q2
$256K Sell
9,161
-1,738
-16% -$47.8K 0.04% 149
2024
Q1
$302K Buy
10,899
+1,738
+19% +$48.2K 0.05% 144
2023
Q4
$264K Hold
9,161
0.05% 140
2023
Q3
$304K Hold
9,161
0.07% 136
2023
Q2
$336K Buy
+9,161
New +$357K 0.07% 127

Other funds holding PFE

Sendero Wealth Management's PFE Position: Q1 2026 in Review

Sendero Wealth Management increased its Pfizer (PFE) stake by 1.8% in Q1 2026, buying an estimated $5.88K and bringing the position to 12,574 shares worth $353K. The position accounts for 0.04% of the portfolio, ranked #174.

Sendero Wealth Management first reported a position in PFE in Q2 2023 and has held it in 12 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Sendero Wealth Management held 12,574 shares of Pfizer worth $353K as of Q1 2026.
  • Sendero Wealth Management bought 221 Pfizer shares in Q1 2026, an estimated $5.88K.
  • Pfizer made up 0.04% of Sendero Wealth Management's portfolio in Q1 2026, its #174 holding.
  • Sendero Wealth Management first reported a position in Pfizer in Q2 2023 and has held it in 12 quarters since.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Sendero Wealth Management's 13F filing for Q1 2026, filed 22 Apr 2026.